When medicine supply chains become weapons: China’s leverage and how the U.S. should respond
Editor’s note: The following is adapted from a testimony given to the U.S. House Select Committee on the…
US drug supply chain exposure to China
Introduction Interest in the exposure of U.S. drug supply chains to China surged during the COVID-19 pandemic, as…